Researchers at the University of Washington have created a molecule that’s more deadly than the most toxic forms of carbon monoxide.
The researchers have described the molecule as a “toxic gas” with “no toxic properties.”
They believe their discovery could be a “game changer” in the fight against cancer and other deadly diseases.
The team, led by Dr. James R. Johnson, used nanoparticles that bind to the carbon in the body to create the toxin.
This means that the carbon can be “reactive to the environment, to our bodies, and to our own bodies,” according to the university’s press release.
“It’s an anti-oxidant, it’s an antiproliferative, it doesn’t do any of the things that make you sick,” Johnson said in a press conference on Tuesday.
The findings, published in Nature Communications, “could be the game changer for cancer therapy,” he said.
“The problem with conventional cancer therapy is that it’s very expensive, it can be very toxic.”
In a paper published in the journal Science, the team describes their new molecule as “toxins that have no toxic properties, but which are very effective at preventing cancer growth and survival.”
Johnson says that the new molecule will likely be more effective at inhibiting the growth of tumors than existing drugs, like the cancer-fighting drugs currently on the market.
The research team, which is affiliated with the University’s College of Science, built the molecule using a method that they call “biological encapsulation.”
This means the molecules can be deposited on the surface of living cells and have a high degree of biocompatibility.
“What you see is that there is very little of the molecule on the cell surface,” Johnson told The Huffington Post in an email.
“But the molecules are very durable, they stick to surfaces for a very long time, and they have good adsorption and diffusion properties, which means they don’t get damaged by the environment or damaged by sunlight or other chemicals that can cause damage to cells.”
Johnson said that, while the team did not specifically describe the mechanism by which this new molecule works, the new mechanism does appear to involve the binding of the carbon to a receptor in the cell membrane.
The mechanism for this binding was also described in the latest edition of Nature Communications.
Johnson and his team used nanoparticle-based encapsulation to create their new toxin.
Johnson explained how it works.
The nanoparticle is placed inside the cell, in a particular region called the membrane.
This membrane is a sort of sponge.
When a chemical comes in through the membrane, it passes through this membrane, where it interacts with a receptor, which attaches to it and activates it, causing the molecule to bind to that receptor.
This receptor is a receptor that’s in your blood vessels, and when you’re exposed to these chemicals, they cause these chemicals to travel through the blood vessels and into your cells.
The molecules can actually get in through your skin, through the airways, through your mucus, and that’s where they can attach to receptors, and these receptors are responsible for their toxicity.
Johnson said this mechanism is a very interesting one.
“One of the interesting things about this is that you have a molecule where you’re binding to a protein that you’re not interacting with, which doesn’t cause a reaction,” he told HuffPost.
“And that molecule actually does cause a chemical reaction that’s harmful, but the molecule doesn’t actually get into your cell and cause a problem.”
Johnson added that, despite its relatively short lifetime, the molecules could be useful in a number of ways.
He noted that the researchers have found that the toxin “can be very useful as a drug.”
“If you have an agent that can be given to cancer cells, and you want to try to kill them, you can use a toxin that’s produced by cancer cells,” Johnson explained.
“You can also use a compound that’s already in your body, but is not metabolized.
This is an agent we’ve found is very effective, very effective against a range of cancer types, but also other cancers that are similar to cancer.
So, it has a broad spectrum of properties that can potentially be used to target and kill these other cancer types.”
Johnson explained that they are now looking to expand their research to look at a wide variety of different diseases, including asthma, diabetes, Alzheimer’s, and many more.
“This is just the beginning of our work on this,” he explained.
Johnson hopes that his research will lead to a new generation of drugs that can prevent disease.
“We’re looking at cancer, we’re looking into other cancers,” he added.
“These are exciting times in the world of medicine.”
“There are so many more exciting things to come.”
He added that his team is currently working on the development of a new class of “cancer-killing drugs,” but he has no firm date on when this will be